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Abstract Energy substrates that are important to the
working muscle at moderate intensities are the non-esteri-
fied fatty acids (NEFAs) taken up from the circulation and
NEFAs originating from lipolysis of the intramuscular
triacylglycerol (IMTAG). Moreover, NEFA from lipolysis
via lipoprotein lipase (LPL) in the muscle of the very-low-
density lipoproteins and in the (semi) post-prandial state
chylomicrons may also contribute. In this review, the
NEFA fluxes and oxidation by skeletal muscle during
prolonged moderate-intensity exercise are described in
terms of the integration of physiological systems. Steps
involved in the regulation of the active muscle NEFA
uptake include (1) increased energy demand; (2) delivery
of NEFA to the muscle; (3) transport of NEFA into the
muscle by NEFA transporters; and (4) activation of the
NEFAs and either oxidation or re-esterification into
IMTAG. The increased metabolic demand of the exercising
muscle is the main driving force for all physiological
regulatory processes. It elicits functional hyperemia,
increasing the recruitment of capillaries and muscle blood
flow resulting in increased NEFA delivery and accessibility
to NEFA transporters and LPL. It also releases epinephrine
that augments adipose tissue NEFA release and thereby
NEFA delivery to the active muscle. Moreover, NEFA
transporters translocate to the plasma membrane, further
increasing the NEFA uptake. The majority of the NEFAs
taken up by the active muscle is oxidized and a minor
portion is re-esterified to IMTAG. Net IMTAG lipolysis
occurs; however, the IMTAG contribution to total fat
oxidation is rather limited compared to plasma-derived
NEFA oxidation, suggesting a complex role and regulation
of IMTAG utilization.
1 Introduction
Limitation of carbohydrate and lipid transfer from the
microvascular system to the muscle cell occurs at the onset
of exercise when the delivery and transport systems are not
optimal and during continuous exercise above moderate
intensities of 50 % of maximal pulmonary oxygen uptake
(VO2max). At higher continuous workloads the extracellular
substrate provision rate is not high enough and intracellular
stored substrates must also be used, such as glycogen and
intramuscular triacylglycerol (IMTAG) [1]. Due to com-
plexity in the regulation of fat metabolism, it is still
unknown what limits active muscle fat oxidation [2–4].
Various suggestions have been put forward, from limitation
in the non-esterified fatty acids (NEFAs) delivery to the
active muscle, to NEFA uptake into muscle or into the
mitochondria or b-oxidation. In addition, the IMTAG not
limited by delivery or uptake seems to be not utilized
optimally as its pool is not even close to fully utilized [5].
The plasma NEFA concentration plays an important role
in the NEFA uptake and subsequent oxidation by the active
muscle. If the plasma NEFA concentration falls, the rate of
muscle NEFA uptake and subsequent oxidation will
decline as well. Conversely, an increase in the plasma
NEFA concentration will increase the active muscle NEFA
uptake and oxidation [6], similar to blood glucose and its
uptake by the active muscle [7]. Adipose tissue release of
NEFAs is the primary source of NEFAs by which the
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plasma NEFA concentration is sustained under post-ab-
sorptive conditions or increased during exercise [8]. Thus,
the control of adipose tissue triacylglycerol (TAG) lipoly-
sis and subsequent release of the NEFAs into the circula-
tion has an important role in the regulation of muscle
NEFA uptake and oxidation during exercise. The liver also
plays an important role as it has a high NEFA uptake and,
thereby, can affect the plasma NEFA concentration, albeit
changes in liver NEFA uptake during exercise are not well-
described [9]. Moreover, the NEFA delivery to the active
muscles (NEFA concentration 9 plasma flow) is an even
better determinant of the NEFA uptake than the NEFA
concentration [10]. The blood flow to the active muscles
increases several-fold upon exercise, primarily to increase
oxygen supply, but it will also increase NEFA delivery.
NEFA uptake from the plasma into the cytosol may occur
to some extent via passive diffusion but over the past
decades it has been shown that the majority of NEFA
uptake occurs via facilitated transport and that muscle
contraction induces plasma membrane fatty acid translo-
case (FAT/CD36) and fatty acid binding protein
(FABPpm) translocation from the intracellular depots to
the plasma membrane [11]. Therefore, NEFA transport into
the muscle cells may be a potential regulatory and limiting
step in NEFA utilization by muscle during exercise. Once
in the cytosol, the NEFA is activated and can either be
oxidized or stored in IMTAG. In this review, the control of
human in vivo NEFA fluxes and subsequent oxidation by
skeletal muscle during prolonged moderate-intensity exer-
cise are described in terms of the integration of physio-
logical systems (Fig. 1).
2 Skeletal Muscle Non-Esterified Fatty Acid
(NEFA) Oxidation During Exercise
from Plasma-Derived NEFA and Intramuscular
Triacylglycerol Lipolysis
The regulation of the active muscle fatty acid uptake and
subsequent oxidation is complex and may be differently
regulated at low, moderate, and high exercise intensities
and durations of exercise. Relatively few studies have
directly determined human muscle NEFA handling during
exercise, with most of the outstanding studies performed in
the 1960–1970s [12–15], and even fewer studies have
determined IMTAG involvement [6]. The limited, but
remarkably consistent, available quantitative and kinetic
information originates from prolonged moderate-intensity
exercise. The regulation of the active muscle NEFA uptake
can be defined by a four-step process, as depicted in Fig. 1,
consisting of (1) an increased energy demand by the con-
tracting muscle; (2) delivery of NEFA to the muscle; (3)
transport of NEFA into the muscle by fatty acids
transporters; and (4) activation of the fatty acids and either
oxidation or re-esterified into intracellular lipids and stored
into the IMTAG droplets located next to the mitochondria.
A similar concept is generally acknowledged for glucose
[7, 16] but differences seem to exist with respect to
glycogen versus IMTAG as the intramuscular carbohydrate
and fat energy stores, respectively.
The increased metabolic rate/demand of the active
muscle is usually not considered to be a regulatory step.
However, it is the main driving force for all physiological
regulatory processes. It elicits functional hyperemia,
increasing muscle blood flow, the number of perfused
capillaries (recruitment), and hormone levels that affect
adipose tissue NEFA release, and hence NEFA delivery to
the active muscle. Moreover, resting skeletal muscle has
very low energy expenditure and thus the demand for
energy/adenosine triphosphate is small, implying that an
increase in energy demand with exercise causes a surge for
substrates that possibly creates a concentration gradient for
NEFA between plasma, the interstitial space, cytosol, and
entry in the mitochondria (Figs. 1, 2).
The resting muscle blood flow is low and 45–55 % of all
NEFA delivered to the muscle is taken up [10, 12, 15, 17]
and is clearly dependent on the NEFA concentration [6].
This suggests that the facilitated muscle NEFA uptake is
limited/saturable or that the lack of substrate demand and/
or re-esterification into intracellular lipids is low, reducing
the NEFA gradient for uptake. During moderate-intensity
exercise the blood flow to the active muscles increases
linearly with the workload [18] and is easily 10- to 15-fold
higher during moderate-intensity exercise [17] than at rest,
and with the increase in blood flow the blood transit time
through the active muscle is substantially reduced [19, 20].
The NEFA fractional extraction decreases to only *20 %
[6, 10, 12–15, 17] as compared to the 45–55 % at rest,
despite the massive increase in blood flow and reduced
transit time. In addition, the NEFA factional extraction is
the same over a wide range of plasma flows [12], i.e.,
exercise intensities, and is independent of the NEFA con-
centration over at least a threefold increase in NEFA
concentration [6, 15]. Accordingly, the active muscle
NEFA uptake is very closely and linearly related to the
NEFA delivery, which is the NEFA concentration multi-
plied by the plasma flow to the active muscle [6, 10, 12–15,
17]. The same relationship is found between NEFA
delivery and NEFA oxidation, since 85–100 % of the
NEFA taken up by the active muscle is directly oxidized
[6, 10, 12–14, 17]. Thus, during exercise the increase in
NEFA uptake with delivery is dependent on the functional
exercise hyperemia increase in blood flow. However, the
linear increase of NEFA delivery and oxidation with the
duration of prolonged moderate-intensity exercise is
caused by the increase in NEFA concentration since the
S24 G. van Hall
123
plasma flow is largely unchanged during continuous exer-
cise at the same intensity, emphasizing the important role
of an increased adipose tissue NEFA release to enhance the
plasma NEFA concentration driving the active muscle
NEFA oxidation (Fig. 1 and Sect. 3) [8]. Consistent with
these findings, an increase in the NEFA concentration via
intralipid/heparin infusion increases the active muscle net
NEFA uptake and fat oxidation [21], and even total fat
oxidation at the relative high workload of 85 % of VO2max
[22]. Conversely, if NEFA concentrations are lowered via
nicotinic acid infusion, the plasma NEFA oxidation is
reduced [23]. The capacity for muscle to achieve such a
rapid and manyfold increase in NEFA uptake upon con-
traction is remarkable, particularly in view of the manyfold
increase in NEFA delivery caused by the massive increase
in blood flow and the substantially reduced time available
for interaction with the NEFA transporters. Of course, the
10- to 15-fold increase in blood flow with moderate-in-
tensity exercise is accompanied by an increased capillary
recruitment [19, 20], also referred to as nutritive flow [24],
increasing the accessibility to NEFA transporters and dif-
fusion surface. In addition, contraction-induced transloca-
tion of NEFA transporters from the intracellular storage
pool to the cell membrane [11, 25] plays an important role
in enhancing muscle NEFA uptake capacity during exer-
cise. Another contributing factor is likely the high energy
demand of the active muscle creating a NEFA surge and
increasing the gradient for NEFA movement from the
mitochondrion to the cytosol and eventual plasma NEFA
uptake.
      NET IMTAG lipolysis 
NEFA     IMTAG synthesis 
                IMTAG lipolysis









NEFA uptake   
    NEFA oxidaon 
    Ketone body producon 
    VLDL-TAG producon 
? 
NEFA oxidaon 








  NEFA transporters 
  Acvaon acyl-CoA synthetase 
Fig. 1 Schematic representation of the control of non-esterified fatty
acid (NEFA) fluxes and oxidation during exercise described in terms
of the integration of physiological systems. Central in the scheme is
the close linear relationship between the active muscle NEFA
delivery and uptake/oxidation observed during continuous moder-
ate-intensity exercise. The increase in NEFA delivery is caused by an
increase in plasma flow that includes capillary recruitment, whereby a
larger portion of the total available NEFA transport machinery
becomes accessible. Plasma flow and capillary recruitment do not
change much with continuous exercise at the same workload; hence,
the increase in muscle NEFA delivery and uptake/oxidation with
exercise duration is mainly mediated by the increase in NEFA
concentration. The increase in the plasma NEFA concentration is
facilitated by an increased release of NEFA from adipose tissue via
increased adipose tissue triacylglycerol (TAG) lipolysis, adipose
tissue blood flow, and capillary recruitment with epinephrine and
possible atrial natriuretic peptide as the key regulators during
exercise. Liver NEFA uptake at rest and during exercise is substantial
but does not seem to change much with exercise, thus it does not have
much effect on the plasma NEFA concentration. Mandatory, but
likely not limiting for NEFA oxidation in healthy individuals, is the
facilitated NEFA uptake by transporters and binding proteins of
which fatty acid translocase (FAT/CD36) and fatty acid bounding
protein (FABPpm) translocate from the intracellular depot(s) to the
plasma membrane with muscle contraction. NEFA from intramuscu-
lar TAG (IMTAG) is used during moderate-intensity exercise. The
net degradation of IMTAG is caused by a decrease in IMTAG
synthesis and maintained or increased lipolysis. Moreover, NEFA
originating from either very-low-density lipoproteins (VLDL-TAG),
or chylomicrons (CM-TAG) primarily in the fed state, may contribute
to the active skeletal muscle NEFA oxidation. Dietary fat reaches the
liver, adipose tissue, and skeletal muscle in the form of CM-TAG that
undergoes lipolysis by lipoprotein lipase (LPL) and the resulting
NEFAs are taken up and either oxidized or esterified by the active
muscle (see also Fig. 2). The contribution of VLDL-TAG- and CM-
TAG-derived NEFA to the resting and active muscle energy
requirements seems limited. ATP adenosine triphosphate, CoA
coenzyme A, GI gastrointestinal
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Over recent decades there has been considerable debate
regarding whether NEFA transport across the plasma
membrane occurs via passive diffusion or via facilitated
transport by means of membrane-associated proteins. The
physical properties of NEFA with a non-polar carbon chain
and the polar head group would make passive diffusion
possible, and this is seemingly supported by the above-
described connection between NEFA concentration and
active muscle NEFA uptake. However, over the past dec-
ade it has been shown that the majority of NEFA is
transported across the cell membrane via protein-mediated
mechanisms. Moreover, some of these fatty acid trans-
porters demonstrate reversible translocation, from the
intracellular storage pool to the cell membrane [11, 25]
under the influence of contraction and insulin, analogous to
























































Fig. 2 Schematic representation of skeletal muscle energy metabo-
lism. Two pathways in skeletal muscle energy oxidation during
exercise can be recognized: the extracellular and intracellular
substrate supply. The increase in the extracellular muscle energy
supply during exercise is mediated via an increase in the blood
substrate delivery of glucose from either carbohydrate intake or liver
glycogenolysis and gluconeogenesis, non-esterified fatty acids
(NEFA) mainly from adipose tissue, and chylomicron or very-low-
density lipoproteins referred to as triacylglycerol (TAG) (see Fig. 1).
The increase in delivery of these substrates to the active muscle is
mediated by an increase in blood flow, including an increase in
capillary recruitment, and substrate concentration. Transport of blood
glucose into skeletal muscle is facilitated by glucose transporter-4
(GLUT4) and the long-chain NEFAs via fatty acid transporters
(FAT), that also facilitates the transport of NEFA into the mitochon-
dria. The fate of the glucose and NEFA taken up by skeletal muscle is
oxidation or storage into glycogen or TAG, respectively. The
intracellular energy supply during exercise is immediately increased,
mainly via a fast breakdown of glycogen crucial to cover the
instantaneously manyfold increase in energy demand going from rest
to exercise. The rate of glycogen breakdown decreases with exercise
duration, and glucose uptake and subsequent oxidation and later fatty
acid oxidation increases. The increase in NEFA availability from
intramuscular triacylglycerol (IMTAG) breakdown during exercise is
mediated by a reduction in NEFA re-esterification and possibly an
increase in IMTAG lipolysis. The role and regulation of the muscle
IMTAG turnover rate is unknown. ACBP acyl-CoA binding protein,
ATGL adipose tissue triglyceride lipase, CoA coenzyme A, DGAT
diacylglycerol acyltransferase, FABP fatty acid binding protein (pm
plasma membrane, c cytosolic), FABPm fatty acid binding protein,
GPAT glycerol-3-phosphate acyltransferase, HSL hormone sensitive
lipase, LPL lipoprotein lipase, MAGL monoacylglycerol lipase, TCA
tricarboxylic acid
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translocation for muscle glucose uptake [7, 16]. Further-
more, studies with FAT/CD36 knockout or overexpressing
mice [26, 27] have lent support to the conclusion that these
fatty acid transporters critically regulate skeletal muscle
fuel selection, performance, and training-induced adapta-
tion of NEFA oxidation [26, 27]. However, while these
studies undoubtedly demonstrate the importance of NEFA
transporters in skeletal muscle NEFA transport from the
plasma into the active muscle, they do not provide infor-
mation on whether these transporters are rate limiting for
NEFA oxidation. The well-described human in vivo
increase in NEFA oxidation with exercise duration and the
close linear relationship between NEFA delivery and
uptake into the active muscle suggests that NEFA uptake is
not solely controlled by the rate of sarcolemmal transport.
This does not exclude an important regulatory role for fatty
acid transporters and translocation of resting muscle NEFA
uptake and its role in NEFA clearance from the circulation,
particularly after food ingestion and during exercise in
untrained individuals or patients with, for example, type 2
diabetes mellitus.
Once NEFA is taken up by the active muscle cell it can
be oxidized or incorporated into intracellular lipid-like
membranes and/or re-esterified and stored into IMTAG.
The rate of resting muscle NEFA re-esterification into
IMTAG is high [6, 28, 29], accounting for *50 to 60 %
of the total NEFA uptake [6, 30]. During exercise the
majority (85–100 %) of NEFA taken up is directly oxi-
dized [6, 10, 12–14, 17] and the rate of re-esterification
into IMTAG is reduced, accounting for *10 % of the
total NEFA uptake [6]. A net IMTAG utilization with
prolonged moderate-intensity exercise is observed for
mixed muscle as a result of a reduced rate of IMTAG
synthesis [6] and potentially an increased IMTAG lipol-
ysis by adipose tissue TAG lipase responsible for the
contraction-induced IMTAG lipolysis [31, 32]. However,
in contrast to glycogen, the mixed muscle IMTAG store
does not seem to be utilized to a large extent (20–50 % of
the pre-exercise total IMTAG [5, 6, 33–35]), and this was
even the case after 12 h of exercise [36]. The mixed
muscle net IMTAG breakdown during exercise may
underestimate IMTAG utilization by the different fiber
types since only type I fibers have been suggested to uti-
lize IMTAG during 2 h of 60 and 75 % of VO2max bicy-
cling exercise [37, 38] as well as after 2 h of high-
intensity knee-extensor exercise [39]. Moreover, type II
fibers have a much lower IMTAG content, but this does
not decrease during exercise [37–39]. The high IMTAG
synthesis rate that is reduced but still continues during
muscle contraction together with a seemingly sub-maxi-
mal utilization rate suggests that the role of IMTAG is not
solely as a rapidly responsive intracellular energy store
such as glycogen, particularly since the higher circulatory
NEFA oxidation shows that the NEFA oxidation capacity
of mitochondria is not limiting for IMTAG utilization.
3 Skeletal Muscle NEFA Supply from Adipose
Tissue Fat Lipolysis During Exercise
Prolonged moderate-intensity exercise in the post-absorp-
tive state causes a continuous increase in the NEFA con-
centration and oxidation with exercise duration [10, 17, 34,
40]. Moreover, the continuous increase in the NEFA con-
centration with duration of exercise implies that the rate of
NEFA entering the circulation is higher than the uptake
rate of the active muscles. Most of the circulatory NEFAs
originate from TAG lipolysis in adipose tissue. Direct
measurements across abdominal subcutaneous adipose
tissue show a substantial increase in NEFA release at low
exercise intensities [41]. Moreover, no or only a modest
increase in adipose tissue NEFA release is found with
higher exercise intensity [9, 41]. Therefore, low-intensity
exercise provides an adequate stimulus for abdominal
adipose tissue NEFA mobilization. The release of NEFA
from subcutaneous adipose tissues depends on the relative
contribution of three processes: (1) adipose tissue TAG
lipolysis; (2) the rate of adipose tissue NEFA re-esterifi-
cation into TAG; and (3) adipose tissue blood flow. The
adipose tissue NEFA uptake is undetectable at rest [9, 42]
and during exercise [9]; hence, NEFA re-esterification does
not play an important role and the increase in adipose tissue
NEFA release can be attributed to an increase in TAG
lipolysis. However, the exercise-induced subcutaneous
adipose tissue blood flow [9, 41, 43] and likely capillary
recruitment [44, 45] plays a crucial role in the increase in
NEFA release during exercise. The difference between the
arterial and adipose tissue venous NEFA concentration is
very similar at rest and during exercise. Therefore, the 2- to
3-fold increase in adipose tissue blood flow during exercise
is responsible for the increase in the circulatory rate of
NEFA [9]. The importance of adipose tissue blood flow for
NEFA release is substantiated by observations in patients
with type 2 diabetes who exhibit an exercise-stimulated
adipose tissue lipolysis but in whom a high fraction of the
liberated NEFA caused by TAG lipolysis could not be
released into the circulation since the exercise-induced
increase in adipose tissue blood flow was much smaller
than in healthy subjects [46]. The exercise-induced
increase in adipose tissue lipolysis and blood flow has
mainly been attributed to the elevated catecholamine con-
centration with exercise [47, 48]. Moreover, circulating
epinephrine is more important than sympathetic nervous
activity for the stimulation of adipose tissue lipolysis dur-
ing exercise [49, 50], albeit differences in various adipose
tissue depots may exist [51]. Whereas epinephrine may be
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primarily responsible for the exercise-induced increase in
lipolysis, selective b-adrenergic blockage does not com-
pletely prevent the increase in lipolysis [47, 48, 52], sug-
gesting that other mediators play a role in the stimulation
of lipolysis during exercise. Atrial natriuretic peptide is a
potential candidate since there is evidence that it stimulates
adipose tissue lipolysis and is produced during exercise in
an intensity-dependent manner [53–55]. Growth hormone
and cortisol increase adipose tissue lipolysis [56–58] and
are potentially involved in the regulation of adipose tissue
lipolysis during exercise. Growth hormone usually increa-
ses with exercise but its effect on lipolysis is not mani-
fested until after 1–2 h of exercise [59] and thus is likely to
become more important during prolonged exercise or be
involved in the enhanced lipolysis during recovery from
exercise [59]. Interestingly, 4 weeks of high-dose growth
hormone supplementation raised the basal lipolytic rate
substantially but did not change the exercise-induced
increase in lipolysis during 30 min of exercise at 65 % of
VO2max [60], suggesting that growth hormone does not
play an important role in the exercise-induced increase in
adipose tissue lipolysis. Cortisol may increase to some
extent with prolonged exercise [61] but this does not
coincide with the rapid increase of adipose tissue TAG
lipolysis upon the start of exercise. It has been suggested
that infused cortisol and growth hormone stimulate sys-
temic and adipose tissue lipolysis in an additive manner;
however, it has to be mentioned that the cortisol levels
were substantially higher than seen for any form of exer-
cise [62]. Interleukin-6 (IL-6) is produced by skeletal
muscle during exercise in increasing amounts with
increased duration [63], and when recombinant human IL-6
(rhIL-6) is infused it increases systemic lipolysis [64].
Thus, IL-6 could be a signal from muscle to adipose tissue
to coordinate the NEFA supply from adipose tissue with
demand from the exercising muscle. However, concomi-
tant IL-6 infusion and exercise fails to raise fatty acid
delivery or oxidation [65], and at rest rhIL-6 infusion does
not increase adipose NEFA release but does increase
NEFA release from skeletal muscle [66]. Therefore, IL-6 is
not a regulator for the increased adipose tissue NEFA
release during exercise, but may be involved in skeletal
muscle TAG utilization during exercise.
It should be noted that most research is performed in the
post-absorptive state and little information exists on adi-
pose tissue NEFA release during exercise in the post-
prandial state. Ingestion of a mixed meal 1 h before exer-
cise causes much lower plasma NEFA concentrations but
does not influence adipose tissue lipolysis [67]. However,
the adipose tissue net NEFA release is substantially lower
during exercise in the post-prandial than in the fasted state
as a result of the high adipose tissue NEFA uptake and re-
esterification into TAG. In addition, the exercise-induced
increase in adipose tissue blood flow is absent post-pran-
dially [67]. Thus, the decrease in the muscle fat oxidation
during exercise after a mixed meal may in part be caused
by reduced NEFA delivery to the active muscle as a con-
sequence of the decreased fatty acid mobilization from
adipose tissue.
4 Skeletal Muscle Fatty Acid Supply from Non-
Adipose Tissue Fat Lipolysis During Exercise
Lipolysis of circulating TAG-rich lipoproteins in the cap-
illaries of skeletal muscle is a source of NEFA for uptake
and either oxidation or re-esterification in the active mus-
cles. The majority of TAG-rich lipoproteins are the very-
low-density lipoproteins (VLDL-TAG) produced in the
liver in the fed and fasted state and contains one molecule
of apolipoprotein B100 and 5–25,000 TAG molecules in its
core [68]. In the fed state chylomicron TAG (CM-TAG) is
secreted by the intestines and begins to appear in the blood
approximately 1 h after the oral fat intake. The large CM-
TAG contain apolipoprotein B48 and are very rich in TAG
with a half-life estimated at 5 min [69]. Both VLDL-TAG
and CM-TAG undergo lipolysis by lipoprotein lipase
(LPL) anchored to heparin sulphate on the endothelial
surfaces in muscle. The affinity of LPL for CM-TAG is
reported to be 50-fold higher than for VLDL-TAG; how-
ever, this is balanced by the usually much higher concen-
tration of VLDL-TAG. Moreover, complex differences
exist between tissues in LPL expression, activity, and
specific nutritional regulation [70, 71]. Circulating CM-
TAGs are suggested to provide a more readily available
source of NEFA for muscle oxidation than VLDL-TAG
[72]. However, this obviously requires oral fat intake
before or during the exercise, something that is not com-
mon practice among athletes. A key problem in the quan-
tification of muscle CM-TAG and VLDL-TAG lipolysis is
the technical difficulty of measuring TAG extraction across
a muscle, a problem that is exaggerated during exercise
when blood flow to the active muscle increases manyfold
[73]. In general, no significant extraction of TAG, CM-
TAG, and VLDL-TAG by the active or inactive muscle can
be determined in the fasted state [10, 73, 74]. However, in
spite of this inability to measure small quantities of muscle
TAG extraction, the potential amount of NEFA for the
muscle can contribute substantially to the total fat oxida-
tion. Enevoldsen et al. [75] did not observe leg TAG uptake
1 h after meal ingestion, but during the following hour a
significant TAG uptake of*45 lmol/min was observed in
only the exercising leg during 1 hour of cycle ergometer
exercise at 50 % of VO2max. The NEFA uptake in the
exercising leg was of similar magnitude; in other words,
the NEFA uptake was only one-third of the TAG uptake in
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NEFA equivalents. Moreover, these results suggest that
exercise per se increases muscle LPL activity, which has
previously been shown not to occur via more direct muscle
LPL activity measurements [76, 77]. However, Enevoldsen
et al. [75] argued that not all capillaries are recruited in the
resting muscle, but that the functional hyperemia of the
active muscle increases the number of perfused capillaries
[24, 78] and, hence, the accessible amount of LPL as de-
picted in Fig. 2. Evidence against a considerable contri-
bution of circulating TAG to active muscle fat oxidation
include findings that in the fasted state the muscle NEFA
uptake and oxidation account for most of the fat oxidation
[6, 10, 12, 14, 15, 17] and also for the majority of whole-
body fat oxidation [37, 79], which suggests that relatively
little of the oxidation of NEFAs originates from CM-TAG
and VLDL-TAG. More research is needed to quantify the
contribution of VLDL-TAG and CM-TAG to muscle fat
oxidation and whether nutritional interventions before or
during exercise can enhance its utilization without com-
promising performance.
5 Discussion
In 1991, Weibel et al. [80] proposed the concept of sym-
morphosis. The concept states that animals and humans
should be designed economically, i.e., that structural
design should be matched to functional demand, or, in
other words, no more structure is built and maintained than
is required to meet functional demand. During very high-
intensity exercise the concept of symmorphosis is put to the
test as it is ultimately the active muscle that sets the aerobic
demand because more than 90 % of energy is spent in the
active muscle. The limitation of carbohydrate and lipid
transfer from the microvascular system to the muscle cell
seems to be reached at the onset of exercise and during
continuous exercise above moderate intensities[50 % of
VO2max. At higher workloads, intracellular stored sub-
strates must be used for oxidation [1]. Glycogen can supply
pyruvate up to the limit of maximal oxidation rates by the
mitochondria, plus a further several-fold increase to fuel
‘anaerobic’ glycolysis. The question is, does IMTAG have
a similar role to glycogen? The IMTAG droplets and the
glycogen granules contain roughly equal amounts of
energy and are in close vicinity to the mitochondria
(Fig. 2). Indeed, IMTAG is utilized during moderate-in-
tensity exercise, but in substantially lower quantities than
plasma NEFA oxidation. In addition, when NEFA con-
centration/availability is low the IMTAG utilization is
increased during moderate-intensity exercise, but it cannot
compensate for the reduction in plasma NEFA oxidation
[23, 81]. In other words, total fat oxidation by the active
muscle is reduced. Enhanced muscle glycogen utilization
has to cover the reduced NEFA oxidation when NEFA
availability is low; if not, the ability to perform prolonged
exercise is impaired [82]. It also demonstrates that NEFA
uptake into the mitochondria and oxidation does not limit
IMTAG utilization. Also different from glycogen is that
IMTAG has an energy-consuming turnover rate of about
1–1.5 of the total IMTAG pool size/day, and, although
IMTAG synthesis during exercise is reduced, it remains at
a substantial rate [6] and it seems that the rate of complete
IMTAG degradation to NEFA cannot be up-regulated very
quickly in response to changes in demand. Therefore, it
appears that IMTAG does not have the role of a rapidly
responsive, directly available fat energy source without
availability or transport limitations during exercise
according to the concept of symmorphosis. Our knowledge
of IMTAG turnover, lipolytic rate, and net utilization is
almost completely lacking under conditions such as food
intake and early versus late and moderate- versus high-
intensity exercise, which makes any hypothesis on the role
of IMTAG daunting. Perhaps IMTAG with its continuous
high turnover rate may act as a ‘buffer’ for intramyocel-
lular NEFAs, which in a high(er) concentration may be
toxic [83, 84] and in a low(er) concentration compromises
energy provision to the active muscles. The high synthesis
and degradation rates for IMTAG mean it is able to fulfil
this dual task. This role could be more important in slow
twitch fibers with higher mitochondrial and IMTAG con-
tent and NEFA oxidation during exercise [37–39].
Research on fiber type differences and muscle NEFA
content, IMTAG turnover, and NEFA transporters under
various exercise conditions are needed to understand the
role of IMTAG, particularly in various metabolic diseases.
Studies on patients with myophosphorylase deficiency
or McArdle disease (also known as glycogen storage dis-
ease V) provide important insights into the role of circu-
latory glucose and NEFA versus intramuscular stored
glycogen and IMTAG. Patients with McArdle disease
cannot break down muscle glycogen and are characterized
by a severely impaired exercise capacity, particularly
during the initial 10 min of exercise, which is followed by
sudden improvement in the exercise capacity referred to as
the ‘second wind’ phenomenon. This second wind is
attributed to an increase in blood glucose uptake [85] that is
higher than in healthy individuals and is mediated by an
increase in the number of GLUT-4 proteins or the local-
ization in the membrane of GLUT-4 [86] and enhanced
muscle blood flow [87]. Moreover, glucose supplementa-
tion greatly improves performance after *5 min of exer-
cise [88]. These findings underscore the important role of
muscle glycogen to cover much of the instant manyfold
increase in energy demand and the initial minute when the
blood flow to the muscle is not yet fully increased to supply
the necessary oxygen for substrate oxidation [18].
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Moreover, the rate of glucose uptake by the active muscles
is far lower than the glucose/glycogen substrate demand for
high exercise intensities. During exercise, patients with
McArdle disease oxidize more circulatory NEFA than
healthy controls exercising at the same intensity [89], but
enhanced availability via intralipid infusion does not
improve performance [90]. The low rate of acetyl-coen-
zyme A (CoA) production from glycolysis cannot be
replaced by a high rate of acetyl-CoA production from the
b-oxidation likely related to reduced availability of
oxaloacetate, tricarboxylic acid cycle intermediates, since
ample pyruvate and/or amino acids are mandatory. Thus,
glycogen is required to oxidize NEFA, whether from cir-
culatory NEFA or IMTAG, with quantities the same as low
to moderate intensities in healthy individuals required for
higher exercise intensities in patients with McArdle
disease.
Our understanding of fat metabolism during exercise is
incomplete, not least the role of IMTAG. Apart from
endurance training, most attempts to increase fat/NEFA
oxidation to improve performance with the rationale of
sparing the carbohydrates for high-intensity exercise have
been rather unsuccessful. Endurance training increases the
capacity of the muscle to take up NEFA [91], potentially
by enhancing the number of capillaries and/or recruitment
and the muscle NEFA oxidative capacity [91]. But how can
we elevate the plasma NEFA concentration, which is an
important determinant of the active muscle NEFA uptake
and subsequent oxidation? Might there be an easier or
additive way to enhance fat oxidation during exercise? This
may be possible via ingestion of small quantities of fat
before and/or during prolonged moderate-intensity exer-
cise, which may aid the endogenous increase in NEFA
release from adipose tissue, particularly during the initial
30 min of exercise when the NEFA concentration slightly
decreases. However, oral glucose intake has been proven to
enhance performance/endurance and should also be pro-
vided, but it will reduce the adipose tissue rate of lipolysis.
Information is lacking but the simultaneous ingestion of
starch with relatively small quantities of fat may potentially
achieve the best results for both carbohydrate and fat uti-
lization and, hence, performance.
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